Avadel Pharmaceuticals plc’s recently made public that its Chief Financial Officer MCHUGH THOMAS S acquired Company’s shares for reported $29000.0 on Jan 16 ’24. In the deal valued at $14.50 per share,2,000 shares were bought. As a result of this transaction, MCHUGH THOMAS S now holds 80,500 shares worth roughly $1.26 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, McCamish Mark Anthony sold 75,000 shares, generating $1,089,750 in total proceeds. Upon selling the shares at $14.53, the Director now owns 67,025 shares.
Before that, MCHUGH THOMAS S bought 2,000 shares. Avadel Pharmaceuticals plc shares valued at $28,900 were divested by the Chief Financial Officer at a price of $14.45 per share. As a result of the transaction, MCHUGH THOMAS S now holds 78,500 shares, worth roughly $1.23 million.
Rodman & Renshaw initiated its Avadel Pharmaceuticals plc [AVDL] rating to a Buy in a research note published on June 12, 2024; the price target was $27. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who remained covering the stock and in early March has reiterated a ‘”an Outperform”‘ rating for it. Needham also remained covering AVDL and reiterated its “Buy” recommendation on March 05, 2024. H.C. Wainwright maintained its rating on March 05, 2024. It rated AVDL as “a Buy”.
Price Performance Review of AVDL
On Monday, Avadel Pharmaceuticals plc [NASDAQ:AVDL] saw its stock fall -0.76% to $15.69. Over the last five days, the stock has gained 2.62%. Avadel Pharmaceuticals plc shares have risen nearly 11.12% since the year began. Nevertheless, the stocks have risen 6.01% over the past one year. While a 52-week high of $19.09 was reached on 05/03/24, a 52-week low of $9.50 was recorded on 03/04/24. SMA at 50 days reached $16.54, while 200 days put it at $14.05. A total of 0.74 million shares were traded, compared to the trading of 0.81 million shares in the previous session.
Levels Of Support And Resistance For AVDL Stock
The 24-hour chart illustrates a support level at 15.49, which if violated will result in even more drops to 15.29. On the upside, there is a resistance level at 15.90. A further resistance level may holdings at 16.11. The Relative Strength Index (RSI) on the 14-day chart is 47.87, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.31, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 25.79%. Stochastics %K at 80.92% indicates the stock is a selling.
The most recent change occurred on February 06, 2024 when UBS began covering the stock and recommended ‘”a Buy”‘ rating along with a $21 price target.
